Biao He

Biao serves as an Investment Partner at TEEC Angel Fund. He is a medical diagnostic expert with the research direction mainly on new methods of gene detection and treatments of human cancers. Biao is co-founder and CTO of Beijing ACCB Biotech Ltd since 2004. The company is committed to the implementation of modern molecular biology technology research and the development of new cancer detection technologies and methods. It also pioneered and promoted the concept of “personalized cancer treatment” in China. In addition, Biao is currently an associate professor of Surgery and Cancer Research Center at University of California, San Francisco (UCSF). Biao holds his Ph.D. in Molecular Genetics from University of Virginia and his bachelor and master degrees in Biology from Tsinghua University, Beijing.